Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients
Boruban, M C, Yasar, U, Babaoglu, M O, Sencan, O, Bozkurt, A
Published in Journal of chemotherapy (Florence) (01.08.2006)
Published in Journal of chemotherapy (Florence) (01.08.2006)
Get more information
Journal Article
The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma
SENCAN, O., BUYUKCELIK, A., YALCIN, B., BORUBAN, M.C., AKBULUT, H., DEMIRKAZIK, A., SENLER, F.C., ONUR, H., ICLI, F.
Published in European journal of cancer care (01.01.2008)
Published in European journal of cancer care (01.01.2008)
Get full text
Journal Article
Correlation of serum leptin level and waist-to-hip ratio (WHR) with overall survival of patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AIs)
Artac, M., Bozcuk, H. S., Kiyici, A., Eren, O. O., Boruban, M. C., Ozdogan, M.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Tamoxifen inhibits cytochrome P450 2C9 activity: A possible mechanism for tamoxifen-warfarin interaction
Boruban, M. C., Babaoglu, M. O., Sencan, O., Bozkurt, A., Yasar, U.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Tamoxifen inhibits cytochrome P450 2C9 activity: A possible mechanism for tamoxifen-warfarin interaction
Boruban, M. C., Babaoglu, M. O., Sencan, O., Bozkurt, A., Yasar, U.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article